[
    [
        {
            "time": "",
            "orginal_text": "2017全球新药研发大年，中国创纪录",
            "features": {
                "keywords": [
                    "新药研发",
                    "全球",
                    "中国",
                    "创纪录"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "2017全球新药研发大年，中国创纪录",
            "scores": {
                "News_content": "2017全球新药研发大年，中国创纪录",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "中国：医疗保健：国家食药监局优先审评令新产品周期加速",
            "features": {
                "keywords": [
                    "国家食药监局",
                    "优先审评",
                    "新产品",
                    "周期加速"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "中国：医疗保健：国家食药监局优先审评令新产品周期加速",
            "scores": {
                "News_content": "中国：医疗保健：国家食药监局优先审评令新产品周期加速",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "三路援军围剿大空头：“全线通杀”之后A股能否逆袭？",
            "features": {
                "keywords": [
                    "三路援军",
                    "大空头",
                    "全线通杀",
                    "A股",
                    "逆袭"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "三路援军围剿大空头：“全线通杀”之后A股能否逆袭？",
            "scores": {
                "News_content": "三路援军围剿大空头：“全线通杀”之后A股能否逆袭？",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "沪指创近半年新低，创业板逆势上涨1.5%",
            "features": {
                "keywords": [
                    "沪指",
                    "新低",
                    "创业板",
                    "逆势上涨"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "指数表现"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "沪指创近半年新低，创业板逆势上涨1.5%",
            "scores": {
                "News_content": "沪指创近半年新低，创业板逆势上涨1.5%",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "[推荐评级]医药生物行业深度研究：以AVASTIN为例看国内外贝伐珠单抗市场-创新药“工具书”系列之单抗(VEGF靶点)",
            "features": {
                "keywords": [
                    "推荐评级",
                    "医药生物",
                    "AVASTIN",
                    "贝伐珠单抗",
                    "单抗",
                    "VEGF靶点"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "[推荐评级]医药生物行业深度研究：以AVASTIN为例看国内外贝伐珠单抗市场-创新药“工具书”系列之单抗(VEGF靶点)",
            "scores": {
                "News_content": "[推荐评级]医药生物行业深度研究：以AVASTIN为例看国内外贝伐珠单抗市场-创新药“工具书”系列之单抗(VEGF靶点)",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "[强于大市评级]医药生物行业专题研究：500亿的PD-1/L1抗体市场空间是如何量化测算的",
            "features": {
                "keywords": [
                    "强于大市评级",
                    "医药生物",
                    "PD-1/L1抗体",
                    "市场空间",
                    "量化测算"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "[强于大市评级]医药生物行业专题研究：500亿的PD-1/L1抗体市场空间是如何量化测算的",
            "scores": {
                "News_content": "[强于大市评级]医药生物行业专题研究：500亿的PD-1/L1抗体市场空间是如何量化测算的",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]